Relationship between Plasma Antioxidants and Thyroid Hormones in Chronic Obstructive Pulmonary Disease

被引:21
|
作者
Mancini, A. [1 ]
Corbo, G. M. [2 ]
Gaballo, A. [2 ]
Raimondo, S. [1 ]
Di Segni, C. [1 ]
Gigliotti, P. [1 ]
Silvestrini, A. [3 ]
Valente, S. [2 ]
Littarru, G. P. [4 ]
Pontecorvi, A. [1 ]
Meucci, E. [3 ]
机构
[1] Univ Cattolica Sacro Cuore, Dept Internal Med, Div Endocrinol, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dept Resp Physiol, I-00168 Rome, Italy
[3] Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, I-00168 Rome, Italy
[4] Polytech Univ Marche, Inst Biochem, Ancona, Italy
关键词
oxidative stress; metabolic features; thyroid hormones; antioxidants; non thyroidal illness; NONTHYROIDAL ILLNESS SYNDROME; EUTHYROID SICK SYNDROME; LOW-DENSITY-LIPOPROTEIN; COENZYME Q(10); OXIDATIVE STRESS; REVERSE T3; TRIIODOTHYRONINE; THYROTROPIN; SECRETION; COPD;
D O I
10.1055/s-0032-1323808
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: A low-T-3 syndrome is observed in chronic diseases, but its treatment is still debated. Chronic obstructive pulmonary disease (COPD) has not been conclusively studied under this aspect. COPD is a complex condition, which cannot be considered a lung-related disorder, but rather a systemic disease also associated to increased oxidative stress. We evaluated thyroid hormones and antioxidant systems, the lipophilic Coenzyme Q(10) (CoQ(10)) and total antioxidant capacity (TAC) in COPD patients to reveal the presence of a low-T3 syndrome in COPD and investigate the correlation between thyroid hormones, lung function parameters and antioxidants. Methods: We studied: 32 COPD patients and 45 controls, evaluating thyrotropin (TSH), free-triiodotyronine (fT(3)), free-tetraiodotyronine (fT(4)), CoQ(10) (also corrected for cholesterol) and TAC. CoQ(10) was assayed by HPLC; TAC by the metmyoglobin-ABTS method and expressed as latency time (LAG) in radical species appearance. Results: We found significantly lower LAG values, fT(3) and fT(4) levels and significantly higher TSH in COPD patients vs. controls. LAG values significantly correlated with fT(3) concentration. 12 out of 32 patients exhibited fT(3) levels lower than normal range. So we divided COPD patients in 2 groups on the basis of the fT(3) concentration (normal fT(3) COPD and low fT(3) COPD). We observed lower LAG values in normal fT(3)-COPD, compared to healthy subjects, with a further significant reduction in low fT(3)-COPD patients. Moreover higher TSH concentration was present in normal fT(3)-COPD, compared to healthy subjects, with a further significant increase in low fT(3)-COPD patients. CoQ(10)/cholesterol ratio was higher in low fT(3)-COPD vs. normal fT(3)-COPD, with a nearly significant difference. Conclusions: These data seem to indicate an increased oxidative stress in low fT(3)-COPD and a role of fT(3) in modulating antioxidant systems. However low fT(3) levels are joined to metabolic indexes of true hypothyroidism, suggesting that elevated CoQ(10) expresses a reduced tissue utilization. These data might suggest the need of thyroid replacement therapy in such a condition.
引用
收藏
页码:623 / 628
页数:6
相关论文
共 50 条
  • [1] Relationships between plasma CoQ10 levels and thyroid hormones in chronic obstructive pulmonary disease
    Mancini, A.
    Corbo, G. M.
    Gaballo, A.
    Valente, S.
    Gigliotti, P.
    Cimino, V.
    De Marinis, L.
    Principi, F.
    Littarru, G. P.
    BIOFACTORS, 2005, 25 (1-4) : 201 - 204
  • [2] Antioxidants and Chronic Obstructive Pulmonary Disease
    Vezina, Felix-Antoine
    Cantin, Andre M.
    CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2018, 5 (04): : 277 - 288
  • [3] Increased Oxidative Stress and Altered Levels of Antioxidants in Chronic Obstructive Pulmonary Disease
    Ahmed Nadeem
    Hanumanthrao Guru Raj
    Sunil Kumar Chhabra
    Inflammation, 2005, 29 : 23 - 32
  • [4] Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease
    Nadeem, A
    Raj, HG
    Chhabra, SK
    INFLAMMATION, 2005, 29 (01) : 23 - 32
  • [5] Mitochondria-Targeted Antioxidants as a Therapeutic Strategy for Chronic Obstructive Pulmonary Disease
    Fairley, Lauren H.
    Das, Shatarupa
    Dharwal, Vivek
    Amorim, Nadia
    Hegarty, Karl J.
    Wadhwa, Ridhima
    Mounika, Guntipally
    Hansbro, Philip M.
    ANTIOXIDANTS, 2023, 12 (04)
  • [6] Physiopathological relationship between chronic obstructive pulmonary disease and insulin resistance
    Cavallari Machado, Felipe Vilaca
    Pitta, Fabio
    Hernandes, Nidia Aparecida
    Bertolini, Gisele Lopes
    ENDOCRINE, 2018, 61 (01) : 17 - 22
  • [7] Decreased activity of butyrylcholinesterase in blood plasma of patients with chronic obstructive pulmonary disease
    Sicinska, Paulina
    Bukowska, Bozena
    Pajak, Aneta
    Koceva-Chyla, Aneta
    Pietras, Tadeusz
    Nizinkowski, Piotr
    Gorski, Pawel
    Koter-Michalak, Maria
    ARCHIVES OF MEDICAL SCIENCE, 2017, 13 (03) : 645 - 651
  • [8] Thyroid Dysfunction in Exacerbation of Chronic Obstructive Pulmonary Disease
    Bahcecioglu, Sakine Nazik
    Koc, Esra Meltem
    Akkale, Tugba Korlu
    Yalcin, Mehmet Muhittin
    Kokturk, Nurdan
    GAZI MEDICAL JOURNAL, 2023, 34 (01): : 22 - 26
  • [9] Plasma Proteomic Signatures in Early Chronic Obstructive Pulmonary Disease
    Baralla, Angela
    Fois, Alessandro G.
    Sotgiu, Elisabetta
    Zinellu, Elisabetta
    Mangoni, Arduino A.
    Sotgia, Salvatore
    Zinellu, Angelo
    Pirina, Pietro
    Carru, Ciriaco
    PROTEOMICS CLINICAL APPLICATIONS, 2018, 12 (03)
  • [10] Evaluation of thyroid dysfunction in chronic obstructive pulmonary disease.
    Madhuri, Gupta
    Vardey, S. K.
    Nalin, Joshi
    Dixit, R.
    BIOMEDICAL RESEARCH-INDIA, 2013, 24 (01): : 110 - 113